Enanta/$ENTA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Enanta
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
Ticker
$ENTA
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
131
ISIN
US29251M1062
Website
Enanta Metrics
BasicAdvanced
$154M
-
-$4.54
0.82
-
Price and volume
Market cap
$154M
Beta
0.82
52-week high
$17.24
52-week low
$4.09
Average daily volume
139K
Financial strength
Current ratio
5.286
Quick ratio
5.093
Long term debt to equity
195.926
Total debt to equity
231.074
Interest coverage (TTM)
-11.86%
Management effectiveness
Return on assets (TTM)
-17.33%
Return on equity (TTM)
-74.26%
Valuation
Price to revenue (TTM)
2.369
Price to book
1.64
Price to tangible book (TTM)
1.64
Price to free cash flow (TTM)
-1.857
Growth
Revenue change (TTM)
-11.55%
Earnings per share change (TTM)
-27.32%
3-year revenue growth (CAGR)
-11.04%
3-year earnings per share growth (CAGR)
-6.34%
What the Analysts think about Enanta
Analyst ratings (Buy, Hold, Sell) for Enanta stock.
Enanta Financial Performance
Revenues and expenses
Enanta Earnings Performance
Company profitability
Enanta News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Enanta stock?
Enanta (ENTA) has a market cap of $154M as of June 04, 2025.
What is the P/E ratio for Enanta stock?
The price to earnings (P/E) ratio for Enanta (ENTA) stock is 0 as of June 04, 2025.
Does Enanta stock pay dividends?
No, Enanta (ENTA) stock does not pay dividends to its shareholders as of June 04, 2025.
When is the next Enanta dividend payment date?
Enanta (ENTA) stock does not pay dividends to its shareholders.
What is the beta indicator for Enanta?
Enanta (ENTA) has a beta rating of 0.82. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.